ConductScience.org, home

Paper41246121

Advancing the Therapeutic Frontier in Thyroid Eye Disease.

Mohammadi SO and 1 other. touchREV Endocrinol, 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Advancing the Therapeutic Frontier in Thyroid Eye Disease. Papers, record 41246121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41246121

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advancing the Therapeutic Frontier in Thyroid Eye Disease.
PubMed
Journal
touchREV Endocrinol
PubMed
Year
2025
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-11-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mohammadi SOSeyed Omid
2Ray CCoby

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125494967Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.J Clin Endocrinol Metab2015https://conductscience.org/library/papers/25494967PubMed
235399971Thyroid eye disease: From pathogenesis to targeted therapies.Taiwan J Ophthalmol2022https://conductscience.org/library/papers/35399971PubMed
340145088Targeted immunotherapies for Graves' thyroidal & orbital diseases.Front Immunol2025https://conductscience.org/library/papers/40145088PubMed
411834423Smoking and thyroid disorders--a meta-analysis.Eur J Endocrinol2002https://conductscience.org/library/papers/11834423PubMed
530081019Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.Am J Ophthalmol2018https://conductscience.org/library/papers/30081019PubMed
639526058Teprotumumab's Impact on Proptosis in Long-duration Thyroid Eye Disease: A Systematic Review and Meta-analysis.touchREV Endocrinol2024https://conductscience.org/library/papers/39526058PubMed
740156757Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress.BioDrugs2025https://conductscience.org/library/papers/40156757PubMed
828467880Teprotumumab for Thyroid-Associated Ophthalmopathy.N Engl J Med2017https://conductscience.org/library/papers/28467880PubMed
926574625Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus.Clin Exp Rheumatol2016https://conductscience.org/library/papers/26574625PubMed
1024967886What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic review.Thyroid2014https://conductscience.org/library/papers/24967886PubMed
1134297684The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.Eur J Endocrinol2021https://conductscience.org/library/papers/34297684PubMed
1238374366The changing landscape of thyroid eye disease: current clinical advances and future outlook.Eye (Lond)2024https://conductscience.org/library/papers/38374366PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42661926Cytokines and drugs targeting cytokines in Graves' disease and thyroid eye disease.Front Immunol2026https://conductscience.org/library/papers/42661926

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41246121

GET https://conductscience.org/api/papers/v1/41246121/authors